Gustavo Mahler, PhD, joined CMC Biologics in 2008 as president. In 2010, he was named global Chief Operations Officer and in January 2016 he became Chief Executive Officer. Prior to joining CMC Biologics, Gustavo worked for 15 years at Bayer in the United States, Europe, and Latin America, serving in various manufacturing and general management positions. He received his PhD in biochemistry from the University of Buenos Aires, and he also has a master of business administration degree from the University UNED of Madrid and an executive certification in management from MIT Sloan.